Cargando…
Engineering of human-type O-glycosylation in Nicotiana benthamiana plants
Therapeutic properties of recombinant proteins are very often affected by the composition and heterogeneity of their glycans. Conventional expression systems for recombinant pharmaceutical proteins typically do not address this problem and produce a mixture of glycoforms that are neither identical t...
Autor principal: | Strasser, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728188/ https://www.ncbi.nlm.nih.gov/pubmed/23147167 http://dx.doi.org/10.4161/bioe.22857 |
Ejemplares similares
-
Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana
por: Ruocco, Valentina, et al.
Publicado: (2022) -
The production of human glucocerebrosidase in glyco‐engineered Nicotiana benthamiana plants
por: Limkul, Juthamard, et al.
Publicado: (2016) -
Engineering a Plant-Derived Astaxanthin Synthetic Pathway Into Nicotiana benthamiana
por: Allen, Quinton M., et al.
Publicado: (2022) -
Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana
por: Margolin, Emmanuel, et al.
Publicado: (2021) -
Engineering of Sialylated Mucin-type O-Glycosylation in Plants
por: Castilho, Alexandra, et al.
Publicado: (2012)